Related Experiment Video
Updated: Jan 31, 2026

Isolation of Mouse Interstitial Valve Cells to Study the Calcification of the Aortic Valve In Vitro
Published on: May 10, 2021
Meis2 represses the osteoblastic transdifferentiation of aortic valve interstitial cells through the Notch1/Twist1
Cheng Sun1, Hanning Liu1, Ke Si2
1National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China; Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Aim:
Calcific aortic valve disease (CAVD) is the most common valvular disease worldwide. The osteoblastic transdifferentiation of aortic valve interstitial cells (VICs) is the essential process of CAVD, but the underlying mechanisms are poorly understood. Aortic VICs are generated from epithelial-to-mesenchymal transition (EMT) and migration of neural crest cells (NCCs).Meis2 has been associated with EMT and NCCs migration during development, but its role in CAVD is unknown. This study aims to elucidate the specific functions of Meis2 and its downstream targets in aortic valve calcification.
Material And Methods:
Levels of Meis2 were examined in calcified (n = 30) and normal (n = 30) human aortic valve tissues, respectively. Meis2 was inhibited in porcine aortic VICs in vitro, and the effect on osteoblastic transdifferentiation and its downstream pathway were studied.
Results:
Meis2 gene and protein expression decreased significantly in calcified human aortic valve tissue compared with the normal ones. Inhibiting Meis2 by siRNAs reduced the gene and protein expression of Notch1 and Twist1, and induced the osteoblastic transdifferentiation of the porcine aortic VICs in vitro.
Conclusions:
The present study indicated that Meis2 repress the osteoblastic transdifferentiation of aortic VICs through the Notch1/Twist1 signaling pathway. The Results identify Meis2 as a potential intervention target for the prevention of CAVD.
Insights
Meis2 normally prevents aortic valve calcification by inhibiting osteoblastic changes in cells. Reduced Meis2 levels promote calcific aortic valve disease (CAVD) via the Notch1/Twist1 pathway, suggesting Meis2 as a therapeutic target.
Area of Science:
- Cardiovascular Biology
- Cellular Biology
- Developmental Biology
Background:
- Calcific aortic valve disease (CAVD) is the most prevalent valvular heart condition globally.
- Osteoblastic transdifferentiation of aortic valve interstitial cells (VICs) is central to CAVD pathogenesis, yet its molecular drivers remain unclear.
- Neural crest cells (NCCs) contribute to VIC development through epithelial-to-mesenchymal transition (EMT) and migration, processes influenced by Meis2.
Purpose of the Study:
- To investigate the role of Meis2 in the development of CAVD.
- To identify the downstream targets and signaling pathways regulated by Meis2 in aortic valve calcification.
Main Methods:
- Quantified Meis2 expression in human calcified and normal aortic valve tissues.
- Utilized siRNA to inhibit Meis2 in porcine aortic VICs in vitro.
- Assessed the impact of Meis2 inhibition on osteoblastic differentiation and Notch1/Twist1 signaling.
Main Results:
- Meis2 gene and protein expression were significantly lower in calcified human aortic valves compared to normal valves.
- Inhibition of Meis2 in vitro led to decreased expression of Notch1 and Twist1.
- Meis2 suppression promoted osteoblastic transdifferentiation of porcine aortic VICs.
Conclusions:
- Meis2 acts as a repressor of VIC osteoblastic transdifferentiation through the Notch1/Twist1 signaling pathway.
- Meis2 is identified as a potential therapeutic target for preventing CAVD progression.
More Related Videos
Related Concept Videos
Forced Transdifferentiation
Artificial...
Repressed Memory
Repressible Operon: trp Operon
Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Mitral Valve Prolapse I: Introduction

